LEO Pharma's therapeutic focus areas

LEO Pharma's vision is to become the number one specialty pharma company worldwide, providing competitive drugs to patients and society within our focus areas.

Our treatments benefit patients suffering from diseases such as


  • Psorisasis
  • Eczema
  • Skin infections
  • Actinic keratosis and non-melanoma skin cancer

Critical Care

  • Thrombosis
  • Nephrology
  • Supportive treatment in cancer

The goal is to improve the quality of life for people with skin conditions and those in need of critical care. As an example, today, psoriasis affects one in 50 people – and our studies show that only half of psoriasis sufferers receive satisfactory treatment. We work to change that.

We start by listening. All the medical conditions in our therapeutic focus areas cause extensive physical and social discomfort, so before we can develop treatments and solutions to help the people with these conditions live better lives, we need to understand the challenges they face.

Drawing on cross-disciplinary expertise from areas such as psychology, sociology and physiology, we create therapies and drugs that are simple and comfortable to administer, ideally requiring only a single daily dose or application and which offer a wide range of drug delivery options.